Pfizer (PFE) announces positive preliminary data from mid-stage study evaluating its 20-valent pneumococcal conjugate vaccine in infants. Completes enrollment in late-stage studies on the vaccine in adults.

source https://finance.yahoo.com/news/pfizers-pneumococcal-vaccine-shows-potential-220610754.html?.tsrc=rss